Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study
- PMID: 18006902
- PMCID: PMC3151653
- DOI: 10.1093/aje/kwm306
Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study
Abstract
In vitro data suggest protective roles for vitamins K and D in inflammation. To examine associations between vitamins K and D and inflammation in vivo, the authors used multiple linear regression analyses, adjusted for age, sex, body mass index, triglyceride concentrations, use of aspirin, use of lipid-lowering medication, season, menopausal status, and hormone replacement therapy. Participants were from the Framingham Offspring Study (1997-2001; n = 1,381; mean age = 59 years; 52% women). Vitamin K status, measured by plasma phylloquinone concentration and phylloquinone intake, was inversely associated with circulating inflammatory markers as a group and with several individual inflammatory biomarkers (p < 0.01). Percentage of undercarboxylated osteocalcin, a functional measure of vitamin K status, was not associated with overall inflammation but was associated with C-reactive protein (p < 0.01). Although plasma 25-hydroxyvitamin D was inversely associated with urinary isoprostane concentration, an indicator of oxidative stress (p < 0.01), overall associations between vitamin D status and inflammation were inconsistent. The observation that high vitamin K status was associated with lower concentrations of inflammatory markers suggests that a possible protective role for vitamin K in inflammation merits further investigation.
References
-
- Baldini V, Mastropasqua M, Francucci CM, D’Erasmo E. Cardiovascular disease and osteoporosis. J Endocrinol Invest. 2005;28:69–72. - PubMed
-
- Clowes JA, Riggs BL, Khosla S. The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev. 2005;208:207–27. - PubMed
-
- Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006;83:456S–460S. - PubMed
-
- Collin-Osdoby P, Rothe L, Anderson F, Nelson M, Maloney W, Osdoby P. Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem. 2001;276:20659–72. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL064753/HL/NHLBI NIH HHS/United States
- N01 HC025195/HC/NHLBI NIH HHS/United States
- R01 HL076784/HL/NHLBI NIH HHS/United States
- 2K24HL04334/HL/NHLBI NIH HHS/United States
- AG028321/AG/NIA NIH HHS/United States
- M01 RR001066/RR/NCRR NIH HHS/United States
- HC-25195/HC/NHLBI NIH HHS/United States
- HL064753/HL/NHLBI NIH HHS/United States
- HL076784/HL/NHLBI NIH HHS/United States
- K24 HL004334/HL/NHLBI NIH HHS/United States
- AG14759/AG/NIA NIH HHS/United States
- T32HL69772-0141/HL/NHLBI NIH HHS/United States
- N01-HC-38038/HC/NHLBI NIH HHS/United States
- R01 HL058090/HL/NHLBI NIH HHS/United States
- HL58090/HL/NHLBI NIH HHS/United States
- R01 AG014759/AG/NIA NIH HHS/United States
- M01-RR-01066/RR/NCRR NIH HHS/United States
- R01 AG028321/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
